For more information or to contact our Spravato team directly, please call us at 1-866-530-5226 or email us at [email protected].
Fast-acting treatment for major depression
Athena Care believes in utilizing all evidence-based treatment options to better serve our clients, including newer medications and modalities of treatment.
That’s why we’ve taken the steps necessary to become one of the first certified Spravato treatment centers in the greater Nashville area.
On March 5, 2019, the U.S. Food and Drug Administration (FDA) approved Spravato™ (esketamine) nasal spray. Spravato is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. Additionally, it’s approved for the quick resolution of major depression with suicidal ideation (MDSI). Spravato is the latest advancement in over a decade approved by the FDA to treat TRD.
What is Spravato?
Spravato is brand name for esketamine produced by Janssen Pharmaceutical Company of Johnson & Johnson. Spravato is only available in a nasal spray form, and only approved by the FDA for treating patients suffering from treatment-resistant depression (TRD) or major depression with suicidal thoughts.
Is Spravato right for me?
Spravato is FDA approved exclusively for adults suffering from Treatment Resistant Depression (TRD) or major depression with suicidal thoughts. Patients suffering from depression are typically considered treatment-resistant if they have not sufficiently responded to at least two different antidepressants of adequate dose and duration in the current depressive episode. To determine if Spravato is right for you, contact our team at Athena Care to discuss your specific situation and treatment options.
Where do I get Spravato?
Although Spravato esketamine is administered as a nasal spray, people will not be permitted to purchase it for home use. To guard against abuse, patients will need to use Spravato under medical supervision at a clinic or doctor’s office that has been certified by the maker of Spravato as an authorized provider. Athena Care is a certified authorized provider of Spravato.
Do I qualify for treatment with Spravato?
Spravato is not for everyone. Spravato is only approved for adults suffering from Treatment Resistant Depression (TRD) or major depression with suicidal thoughts. Your doctor will work with you to determine if you qualify for Spravato. Contact us to discuss your specific situation, review the qualification requirements, and learn about treatment options.
Does my insurance cover Spravato?
Most insurance providers are now offering coverage for qualified patients. As a first step, contact Athena Care and our team will help you understand your insurance coverage and other possible affordability options. Or you may fill in our insurance verification form included at the bottom of this page.
Where do I go to get Spravato treatments?
Spravato treatments are administered under the supervision of a medical doctor and the supporting medical staff at Athena Care. Spravato is not available for use outside the medical clinic.
What are the potential side effects and risks of Spravato?
Contact us to learn more about Spravato. For additional information about Spravato from Janssen Pharmaceuticals, Inc., the maker of Spravato, visit www.spravato.com
How can I get more information about Spravato?
Call an Athena Care Spravato specialist at 1-866-530-5226.